OmniAb, Inc. (OABI)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about OmniAb, Inc. (OABI)
Company Performance

Current Price

as of Oct 16, 2024

$4.06

P/E Ratio

N/A

Market Cap

$479.74M

Description

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. Its platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.

Metrics

Overview

  • HQEmeryville, CA
  • SectorCommercial Services
  • IndustryMiscellaneous Commercial Services
  • TickerOABI
  • Price$4.06+2.78%

Trading Information

  • Market Cap$479.74M
  • Float80.57%
  • Average Daily Volume (1m)322,877
  • Average Daily Volume (3m)424,189
  • EPS-$0.62

Company

  • Revenue$21.71M
  • Rev Growth (1yr)9.62%
  • Net Income-$13.63M
  • Gross Margin19.87%
  • EBITDA Margin-167.17%
  • EBITDA-$12.73M
  • EV$347.57M
  • EV/Revenue16.01
  • P/EN/A
  • P/S18.97
  • P/B1.63
Documents